2021 · Life · open access
Use of Quantitative Dried Blood Spots to Evaluate the Post-Vaccination Level of Neutralizing Antibodies against SARS-CoV-2
Marchand et al.
The finding, in our words
A quantitative dried blood spot device (Capitainer qDBS) combined with the Roche Elecsys anti-SARS-CoV-2 S immunoassay tracked anti-spike antibody development after two doses of the Pfizer vaccine, with the second dose producing a roughly hundredfold stimulation that peaked at two weeks and fell to 65 percent by three months. The bias between plasma and DBS was variable across both a 14-volunteer vaccination cohort and a 200-patient clinical cohort, yet DBS proved sufficiently sensitive for prolonged immune-status monitoring without venous draws.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.